Non-Valvular Artial Fibrillation Drug Xarelto® (Rivaroxaban), Studies Investigate Benefits

Patients with Atrial Fibrillation (AF) who undergo cardioversion or catheter ablation therapy are at particular risk of stroke and require effective anticoagulation before and after these procedures. Xarelto is indicated for the prevention of stroke and systemic embolism in eligible adult patients with non-valvular atrial fibrillation with one or more risk factors such as: congestive heart failure, hypertension, age�75 years, diabetes mellitus and prior stroke or transient ischaemic attack... via Health News from Medical News Today Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2012/08/non-valvular-artial-fibrillation-drug.html